Using the drugs currently prescribed for schizophrenia or bipolar disorder is like undergoing chemotherapy, he said. “There’s ...

The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline/trospium chloride), a new medication offering a novel approach to treating schizophrenia, marking the first new type of ...

For around 70 years, the treatment of schizophrenia has relied almost entirely on drugs that block dopamine receptors, so Cobenfy's action on cholinergic receptors offers a brand new way to treat ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Much of the recent buzz in the schizophrenia space has ...